Please use this identifier to cite or link to this item:
https://repository.iimb.ac.in/handle/2074/11551
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Gamalo, Mark A | - |
dc.contributor.author | Muthukumarana, Saman | - |
dc.contributor.author | Ghosh, Pulak | - |
dc.contributor.author | Tiwari, Ram C | - |
dc.date.accessioned | 2020-04-10T13:25:47Z | - |
dc.date.available | 2020-04-10T13:25:47Z | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 0962-2802 | - |
dc.identifier.uri | https://repository.iimb.ac.in/handle/2074/11551 | - |
dc.description.abstract | The existing generalized p-value approach, from statistical literature, is applied to assess noninferiority of an experimental treatment in a three-arm clinical trial including a placebo. Two generalized test functions (GTFs) are constructed and Monte Carlo simulations are used to compute the p-value. The GTFs perform well in terms of maintaining the Type-I error probabilities, and the power of the tests are shown to increase to 1 as both the sample size and the parameter denoting the fraction of the effect of the reference drug with respect to placebo increase. The generalized confidence intervals are shown to retain the coverage probabilities. A published dataset is re-analysed using the proposed test and the results are in agreement with earlier findings. | - |
dc.publisher | Sage Publications Ltd. | - |
dc.subject | Behrens-Fisher Problem | - |
dc.subject | Coverage Probability | - |
dc.subject | Dirichlet Distribution | - |
dc.subject | Generalized Test Function | - |
dc.subject | Noninferiority | - |
dc.subject | Type-I Error | - |
dc.title | A generalized p-value approach for assessing noninferiority in a three-arm trial | - |
dc.type | Journal Article | - |
dc.identifier.doi | 10.1177/0962280210395739 | - |
dc.pages | 261-277p. | - |
dc.vol.no | Vol.22 | - |
dc.issue.no | Iss.3 | - |
dc.journal.name | Statistical Methods in Medical Research | - |
Appears in Collections: | 2010-2019 |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.